Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Perrigo Consumer Results' Significance Grows With Tysabri In Past

Executive Summary

Firm reclassifies previous revenues from its now-divested license for Tysabri royalties, garnering tax benefits in earlier periods. Perrigo's review of its 2014-2016 results also uncovered $19m in 2016 net income for its European consumer products business.


Related Content

Perrigo Closes Q1 Earnings Saga Trying To Keep Grip On Rx Business
Perrigo's Return To OTC Roots Restoring Investor Confidence
Perrigo Trims Workforce, Ships Tysabri License, Stays European Course


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts